EMOttawa Blog
  • Ottawa Handbook of Emergency Medicine
  • EMOttawa Podcast
  • Point-of-Care Echo
  • Grand Round Summaries
  • Journal Club
  • Commentary
  • Ultrasound
  • Infographics
  • Canadian TIA Score
  • EDI
  • Prehospital and Transport Medicine
  • Ottawa Acute Care Resources
  • About Us
Select Page
Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial

Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial

by Hans Rosenberg | Mar 1, 2021 | Chronic Pain, Journal Club

Methodology: 3.5/5 Usefulness: 3/5 Ruberto AJ, et al. Ann Emerg Med. 2020 Nov 5:S0196-0644(20)30666-1 Question and Methods: Randomized control trial in which cannabis users with active emesis received either haloperidol (0.05mg/kg or 0.1 mg/kg IV) or ondansetron 8mg...

Ondansetron compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial.

by emottawa | Jul 6, 2015 | Journal Club

Journal Club Summary Methodology Score: 3/5                    Usefulness Score: 2/5   Abas MN, Tan PC, Azmi N, Omar SZ. Obstet Gynecol. 2014 Jun;123(6):1272-9. Abstract Link    This small RCT found that ondansetron was not superior in efficacy to metaclopramide for...

Ondansetron and the Risk of Cardiac Arrhythmias: A Systematic Review and Postmarketing Analysis

by emottawa | Jan 12, 2015 | Journal Club

Journal Club Summary Methodology Score:    3.5/5                 Usefulness Score:  2/5   Freedman SB, Uleryk E, Rumantir M, Finkelstein Y. Ann Emerg Med. 2014 Jul;64(1):19-25.e6. Article Link   This retrospective review of adverse drug reaction (ADR) registries and...
  • Facebook
  • Twitter
  • Instagram
  • YouTube

Mission Statement

World-Class Emergency Medicine: To provide outstanding compassionate emergency care through practice-changing research and innovative medical education. For more about our department, visit us at EMOttawa.

Categories

Free Open Access Medical Education content by EMOttawa is under a Creative Commons Attribution-NonCommercial ShareAlike 4.0 International License.